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Tbjective: Neonates with profound heart failure resulting from Ebstein anomaly
ave historically had poor outcomes. We report our institutional experience with the
urgical management of Ebstein anomaly in severely symptomatic neonates.
ethods: A retrospective review of all patients (n  16) undergoing neonatal inter-
ention for Ebstein anomaly between 1992 and 2005 has been carried out. The
ndications for operation were overt heart failure, cyanosis, and acidosis associated with
ricuspid regurgitation, depressed right ventricular function, and severe cardiomegaly.
he magnitude of cardiac enlargement was assessed by cardiothoracic ratio and Great
rmond Street ratio (area of right atrium  atrialized right ventricle/area of functional
eft atrium left ventricle). The operative strategy was first to assess for the possibility
f tricuspid valve repair with or without right ventricular outflow tract reconstruction. If
his was not feasible, then right ventricular exclusion was performed by oversewing the
ricuspid valve with a pericardial patch. A reduction atrioplasty was done and, depend-
ng on the extent of the atrialized portion of the right ventricle, plication was performed.
modified Blalock-Taussig shunt provided pulmonary blood flow. This univentricular
pproach (Starnes procedure) evolved to include a fenestration in the tricuspid valve
atch to allow for right ventricular decompression. Analysis included overall and
roup-specific survival as well as the testing of perioperative clinical, morphologic, and
urgical variables for correlation with mortality and morbidity.
esults: Mean age and weight at operation were 8 10 days and 3.1  0.4 kg.
ricuspid valve repair was undertaken in 3 patients with 1 requiring conversion to
ight ventricular exclusion 3 months after the initial operation. In those with right
entricular exclusion, the tricuspid valve patch was fenestrated in 10 and nonfenes-
rated in 3. One patient had heart transplant as the initial procedure. There were 5
ospital deaths (31%) and no late deaths among the survivors. Survival in the cohort
ith a fenestrated tricuspid valve patch was 80% (8/10) versus 33% (1/3) for the
onfenestrated group. This difference did not reach statistical significance, although
he trend seems clinically important. There was no difference in the cardiothoracic
atio (0.82 fenestrated vs 0.84 nonfenestrated: P .802) or the Great Ormond Street
atio (1.2 fenestrated vs 1.02 nonfenestrated: P  .477) between the two groups.
mong the 9 survivors of right ventricular exclusion, 3 have had completion of their
ontan, and all 9 have undergone a bidirectional Glenn procedure. All operations
ncluding homograft placement in the right ventricular outflow tract, whether during
epair or during right ventricular exclusion, ended in death.
onclusion: Right ventricular exclusion with a fenestrated tricuspid valve patch
ombined with right atrioplasty and right ventriculoplasty and a Blalock-Taussig
hunt (Starnes procedure) has provided effective palliation for neonates presenting
ith critical Ebstein anomaly and a tricuspid valve that cannot be repaired.
eonates with symptomatic Ebstein anomaly continue to be a difficult
management problem. The disease process is much different from that of
children or adults who present later in life with progressive tricuspidegurgitation and arrhythmias. Neonates can have a rapidly deteriorating course
he Journal of Thoracic and Cardiovascular Surgery ● Volume 132, Number 6 1285
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Dith severe heart failure, cyanosis, and acidosis. Without
urgical intervention most will die. This subgroup has his-
orically had dismal outcomes with medical therapy, and
ntil recently surgical intervention had little more to offer,
ith tricuspid valve repair or replacement associated with
igh mortality.1-3 Because of this, a right ventricular (RV)
xclusion approach was developed and first reported by
tarnes and associates4 in 1991. This procedure included
atching of the tricuspid valve and a modified Blalock-
aussig shunt. Since the first reported series of RV exclu-
ion, 16 additional neonates with extreme Ebstein anomaly
ave undergone palliation at our institution. This report re-
iews the evolution of our surgical management of these
eonates and includes their intermediate-term outcomes.
atients and Methods
retrospective review of 16 consecutive neonates with critical
bstein anomaly presenting between 1992 and 2005 has been
arried out. Institutional approval was obtained before the incep-
ion of the study.
emographics and Preoperative Status
he patients presented in the first days of life with severe cardio-
egaly and heart failure. There were 9 girls and 7 boys with a
ean weight of 3.12  0.47 kg. Two neonates were premature
estimated 33 weeks of gestation). Six patients had a prenatal
iagnosis by fetal echocardiography. In the remainder, the diagnosis
as made after discovery of a murmur (n  2) or cyanosis (n  8).
here were associated cardiac findings in most patients, including
atent ductus arteriosus (n  11), atrial septal defect (n  12), and
ulmonary valve stenosis or atresia (n  8).
All 16 neonates were intubated and supported with a ventilator
efore repair. Fourteen (88%) required prostaglandin E to ensure
uctal patency, and 9 (56%) required inotropes (dopamine, dobut-
mine, or epinephrine).
reoperative Assessment
he cardiothoracic ratio was measured from a chest x-ray film for
ach patient. Additionally, a Great Ormond Street score was cal-
ulated from an echocardiogram as described by Celermajer and
ssociates.5 This measure of the degree of right heart dilation is
etermined by the ratio of the combined area of the right atrium
nd atrialized portion of the RV divided by the area of the func-
ional RV added to the area of the left heart chambers (in diastole).
ratio greater than 1 has previously been found to correlate with
n overwhelming risk of mortality.3,6 The Great Ormond Street
atio has also been arbitrarily expressed as a severity score ranging
Abbreviations and Acronyms
PA  pulmonary artery
RV  right ventricle(ular)
RVOT right ventricular outflow tractrom 1 to 4. Grade 1 is characterized as a ratio less than 0.5; grade u
286 The Journal of Thoracic and Cardiovascular Surgery ● Dec, 0.5 to 0.99; grade 3, 1.0 to 1.49; and grade 4, equal to or greater
han 1.5.
urgical Technique
ia a median sternotomy, standard aortic and bicaval cannulation
s performed, and under moderate hypothermia (28°C), the heart is
rrested with cold blood cardioplegic solution. Through an oblique
ight atriotomy, the tricuspid valve is inspected and evaluated for
ossible repair. The degree of atrialized versus trabeculated (func-
ional) RV is determined. Next the leaflet tissue is addressed. Most
mportant, the ability to mobilize the anterior leaflet is evaluated
ecause this leaflet must guard the majority of the neo-tricuspid
alve orifice. The remnants of the small tethered septal and pos-
erior leaflets also are assessed for the ability to integrate these
tructures into the repair. The right ventricular outflow tract
RVOT) is investigated. Any pulmonary stenosis or atresia must be
ddressed as part of a possible repair. If the ventricle is tripartite
nd the tricuspid valve tissue is adequate, repair of the valve is
ndertaken as described by Danielson and colleagues.7
If the tricuspid valve is not amenable to repair, or the functional
ortion of the RV is inadequate, or there is RVOT obstruction that
annot be reasonably corrected, then an RV exclusion (univen-
ricular) strategy is undertaken. This is performed by patching the
ricuspid valve with glutaraldehyde-fixed autologous pericardium
ewn at the “anatomic” level of the tricuspid annulus. A 4-mm
enestration of the patch is then performed with a coronary punch.
he coronary sinus is left on the right atrial side of the patch (in
eference to the original description by Starnes and associates4).
n unobstructed atrial septal opening is assured. A reduction right
trioplasty is carried out and, depending on the size of the atrial-
zed portion, an RV plication is performed. Care is taken to avoid
inking of the right coronary artery. Next the RVOT is accessed.
arly in the experience, when no fenestration of the patch was
erformed, small homografts were placed in the RVOT to assure
n avenue for RV decompression. Since the introduction of the
enestration, this has not been needed. However, pulmonary valve
nsufficiency is treated with main pulmonary artery (PA) interrup-
ion. Finally, pulmonary blood flow is provided by a modified
lalock-Taussig shunt (3.5-4.0 mm) (Figures 1 and 2). The ster-
um is electively left open; the average time to closure was 2 days
rom the original operation.
esults
reoperative Imaging
he mean cardiothoracic and Great Ormond Street ratios
ere 0.89  0.09 and 1.07  0.55, respectively. The mean
reat Ormond Street severity score was 3. Neither ratio was
statistically significant predictor of mortality.
perative Course
he median age at the initial palliative operation was 8 days
range 1-15 days). Three patients had tricuspid valve repair.
ne of these 3 patients was subsequently converted to RV
xclusion 81 days after the initial valve repair. Because of
xtreme ventricular dysfunction, 1 patient underwent trans-
lantation as the initial operation. Twelve of 16 patients
nderwent RV exclusion as their initial palliation. Ten of
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Dhe exclusion procedures included a fenestration in the RV
atch. There was no difference in bypass or aortic cross-
lamp time between those undergoing repair versus RV
xclusion (bypass time 66  2 minutes; aortic crossclamp
ime 26  6 minutes). No heart block was observed perio-
eratively in any treatment group.
VOT Management
en of the 13 patients who underwent RV exclusion had
ulmonary atresia or severe pulmonary stenosis. Two pa-
ients early in the RV exclusion experience underwent
lacement of an RV-PA homograft. One patient had fenes-
ration of the patch and the other did not; both patients died.
wo of the 3 patients who underwent valve repairs required
rocedures to augment the RVOT: one had an autologous
ericardial transannular patch and the other had placement
f an RV-PA homograft. The patient who underwent the
VOT patch was subsequently converted to RV exclusion
nd the pulmonary outflow was interrupted. All patients
ho had homograft placement as a part of their operation
ad poor outcomes.
urvival
here were 5 hospital deaths at a median interval of 10.2 days
ostoperatively (range 0-20 days). There were no late deaths
hrough an intermediate-term mean follow-up of 27 months
range 8-168 months). Among the 3 patients undergoing valve
epair, 1 died, 1 had subsequent conversion to RV exclusion,
nd 1 is a long-term survivor. Only 1 of 3 patients with an
nfenestrated tricuspid valve patch survived (33%) whereas 8
f 10 (80%) are alive after RV exclusion with fenestration. The
mall number of patients in the nonfenestrated cohort pre-
ludes a statistical verification of the difference between these
igure 1. A glutaraldehyde-fixed autologous pericardial patch is
ewn at the “anatomic” level of the tricuspid valve annulus. ASD,
trial septal defect.roups (Figure 3, Table 1). m
The Journal of ThoracicAll 9 survivors of RV exclusion have undergone a suc-
essful bidirectional Glenn shunt. Three have had success-
ul Fontan completion. The remaining are Fontan candi-
ates awaiting the appropriate time for their procedure.
here have been no unexpected reoperations in this cohort.
iscussion
or a highly symptomatic neonate, the diagnosis of Ebstein
nomaly formerly meant almost certain death. The anomaly
tself presents with a range of anatomic features and clinical
resentations. The valve may have minimal changes or it
ay be markedly displaced and adherent to an almost
ompletely atrialized RV chamber. The surgical goal should
e to palliate for optimum survival, and this may be accom-
lished with valve repair, RV exclusion, or transplantation.
he anatomy will dictate the most appropriate palliation.
lthough Knott-Craig and colleagues8,9 have described tri-
uspid valve repair for the full spectrum of neonates and
nfants with excellent short- and mid-term results, theirs
ppears to be an isolated experience.
The RV exclusion procedure should have its biggest
mpact at the more severe end of the Ebstein spectrum
here there is a diminutive true RV, highly laminated leaflet
issue, unguarded tricuspid valve orifice, and an obstructed
VOT. This is associated with marked dilation of the right
ide of the heart and subsequent impingement on the left
entricle. The RV exclusion technique decompresses the
ight side, allowing the left ventricle to function more ef-
ectively. Furthermore, in cases in which severe RVOT
bstruction or atresia is present, RV exclusion eliminates
he need for RVOT repair. This simplifies the initial palli-
tion and precludes future procedures for conduit obstruc-
ion or insufficiency. The statement that a good single-
entricle repair is better than a bad 2-ventricle repair may
pply to such cases.10 Additionally, the potential benefit of
morphologically left ventricle providing systemic outflow
igure 2. A 4-mm coronary punch is used to create a fenestration
n the patch. The coronary sinus remains on the right atrial side
f the patch.ay aid these palliated patients.
and Cardiovascular Surgery ● Volume 132, Number 6 1287
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DThe downside of the RV exclusion procedure is a com-
itment to the single-ventricle Fontan pathway, which cur-
ently requires at least two subsequent operations after
nitial palliation. Although few patients have undergone a
uccessful valve repair after RV exclusion, there is prece-
ence.8 There is also the potential for a one and a half
entricle repair after palliation by RV exclusion.
Another potential problem with single-ventricle repair in
ssociation with Ebstein anomaly is difficult access for
atheter ablation of arrhythmias. However, late arrhythmias
ave not been a problem in our patients, and it may be that
V exclusion will decrease the incidence of atrial arrhyth-
ias by eliminating important right atrial enlargement.
It is noteworthy that reports of valve repair for Ebstein
nomaly describe residual tricuspid regurgitation in a ma-
ority of patients despite adequate repair.11,12 Tricuspid in-
ufficiency combined with RVOT obstruction or pulmonary
alve insufficiency may provide a substrate for a distention
f the right atrium and subsequent late arrhythmias.
The RV exclusion technique has evolved over the 10 years
ince it was first described. Two elements have emerged with
egard to optimal right-sided decompression. First, the coro-
ary sinus has been retained on the right atrial side of the
ricuspid valve patch. This is important because it leaves as
ABLE 1. Survival
Survival
One month (%) One year (%) Five years (%)
enestrated 80 80 80
onfenestrated 66 33 33
alve repair 66 50 50t
ll patients 81 69 89
288 The Journal of Thoracic and Cardiovascular Surgery ● Decittle blood draining into the excluded RV as possible. Our
xperience suggests that placement of the tricuspid valve patch
o as to leave normal coronary sinus drainage can be accom-
lished without a major risk of injury to the conduction tissue.
owever, it is recognized that in general there may be an
ncreased risk to the conduction tissue in Ebstein patients
wing to the reported malpositioned atrioventricular node in
ome patients.13
The second and more significant modification to the RV
xclusion technique has been the addition of a fenestration
o the tricuspid valve patch. The fenestration was added
fter a patient with pulmonary atresia had persistent RV
ilation. Since this experience we have advocated fenestra-
ion. This allows RV decompression, relieving impingement
n the left ventricle with subsequent improvement in the
ystemic circulation. With the RV decompressed, an argu-
ent can be made to eliminate RV plication, which should
ecrease the potential risk of coronary artery distortion.
Transplantation should remain in the armamentarium
hen dealing with Ebstein anomaly. Particularly in the case
f left-sided obstruction associated with Ebstein malforma-
ion, evaluation for transplantation should be seriously con-
idered because such infants have a poor outcome with
niventricular repair. Given the current shortage of donor
earts, these neonates may be considered for an ABO-
ncompatible transplant to shorten the time on the waiting
ist. Mechanical support may also be required before a
uitable donor becomes available.
In conclusion, we have sought to develop a systematic
perative approach to neonates with symptomatic Ebstein
nomaly. The tricuspid valve and RV should be evaluated
or possible repair. In severe cases in which successful
Figure 3. Survival among treatment
groups.ricuspid valve repair appears uncertain, we advocate RV
ember 2006
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Dxclusion with fenestration and a systemic-to-pulmonary
hunt. This surgical strategy has provided effective pallia-
ion for a group of patients that has historically had poor
utcomes. For severe cases of Ebstein anomaly with asso-
iated left heart obstructive defects, transplantation should
e considered.
imitations
lthough this is a relatively large series dealing with sur-
ical intervention for neonates with Ebstein malformation
resenting in a fulminate manner, the total number of pa-
ients is small and the power of the study is therefore
ffected. Additionally, the RV exclusion technique devel-
ped in a stepwise fashion, which did not allow for ran-
omization to better elucidate the difference between pa-
ients with and without fenestration. Finally, we recognize
hat we may use the RV exclusion technique more readily
ecause of our institutional experience and outcomes.
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iscussion
r Christopher J. Knott-Craig (Oklahoma City, Okla). I rise to
ongratulate you on the first major presentation on patients with
eonatal Ebstein anomaly and on the continued results that you h
The Journal of Thoracicave shared with us. In your presentation you review a 14-year
xperience with 16 patients, most of whom underwent RV exclu-
ion and have excellent outcomes based on historical norms.
We also have a good experience with neonatal Ebstein patients,
aving had the opportunity to operate on 22 of these patients over
2 years; we have taken a different approach in that we have
ttempted a 2-ventricle repair in all of them with a greater than
0% survival.
Clearly, there is room to do an RV exclusion operation and
here is room to do a 2-ventricle repair. The dilemma that we face
s surgeons is trying to stratify which patients would do better with
ne operation versus the other. Can you help us make a decision
ased on your experience? Do you have any insights that you
ould share with us based on your most recent experience in this
egard?
Dr Reemtsen. I think the million-dollar question is, when
hould this be done? We think of the RV exclusion as more of a
ool to deal with Ebstein anomaly than as an answer. If the valve
issue looks good and we think we can approach a repair and there
s a tripartite ventricle with an open RVOT, then we absolutely will
ttempt to repair the malformation. If we are not able to do, by
chocardiogram, an adequate repair, we would do an RV exclusion
t that point.
I think the more difficult group is the one in which there is
ailure at delamination, there is really no identifiable leaflet tissue,
nd there is an obstructed RVOT. I do not think, at least in our
ands, that we can get an adequate repair as well as we have now.
e have to open up the RVOT with a small homograft, and we all
now the implications of that.
Trying to see whether there is a usable ventricle is our main
oal, as well as valve tissue that will give us a repair that would be
ess than mild, mild or less, on an echocardiogram.
Dr Knott-Craig. One may argue that if you do a very aggres-
ive tricuspid valve annuloplasty and have a regurgitant valve at
he end, you may, at least physiologically, have pretty much the
ame results as if you sew a patch of tissue to the tricuspid valve
nnulus and fenestrate it. I think ultimately the two end points may
ot be very dissimilar, at least in a certain group of patients.
Could you tell us a little bit about the patient in whom a heart
ransplant was performed? How did you decide on transplantation
or that patient in contradistinction to the other patients?
Dr Reemtsen. This patient was the only one who had really
evere left-sided malformations, had hypoplasia of the mitral valve
elatively, and had moderate valve regurgitation in association
ith a coarctation. We believed that surgery would be high risk in
his patient, who had a univentricular heart with the only valve
eing the mitral valve, so we listed that patient as soon as we
ould.
Dr Knott-Craig. My final question relates to your entire cohort
f patients. Is it possible that some of these patients might not need
n operation in the early postpartum period? How did you differ-
ntiate between these and the really sick neonates? How did you
tabilized them in the preoperative period?
Dr Reemtsen. We didn’t stabilize them. Essentially, the pa-
ients that we operated on had not responded to medical therapy. I
now that there is a movement now to incorporate nitric oxide and
ry to get these patients out of the neonatal period, but we do not
ave a lot of experience with that approach. I think if that is able
and Cardiovascular Surgery ● Volume 132, Number 6 1289
